These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19100547)

  • 1. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population.
    Kiechl S; Lee T; Santer P; Thompson G; Tsimikas S; Egger G; Holt DW; Willeit J; Xu Q; Mayr M
    Atherosclerosis; 2009 Jul; 205(1):261-5. PubMed ID: 19100547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
    Jud P; Hafner F; Verheyen N; Gary T; Meinitzer A; Brodmann M; Seinost G; Hackl G
    Heart Vessels; 2018 Dec; 33(12):1453-1462. PubMed ID: 29946762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).
    Tain YL; Hsu CN
    Toxins (Basel); 2017 Mar; 9(3):. PubMed ID: 28272322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
    Oliva-Damaso E; Oliva-Damaso N; Rodriguez-Esparragon F; Payan J; Baamonde-Laborda E; Gonzalez-Cabrera F; Santana-Estupiñan R; Rodriguez-Perez JC
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
    Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
    Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
    Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study.
    Mels CMC; Schutte AE; Huisman HW; Smith W; Kruger R; van Rooyen JM; Schwedhelm E; Atzler D; Böger RH; Malan NT; Malan L
    Amino Acids; 2017 Nov; 49(11):1843-1853. PubMed ID: 28831582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
    Gore MO; Lüneburg N; Schwedhelm E; Ayers CR; Anderssohn M; Khera A; Atzler D; de Lemos JA; Grant PJ; McGuire DK; Böger RH
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2682-8. PubMed ID: 24008162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethylarginines correlate to common carotid artery wall layer dimensions and cardiovascular risk factors in pregnant women with/without preeclampsia: A group comparative study.
    Akhter T; Wikström G; Larsson M; Bondesson U; Hedeland M; Naessen T
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():288-293. PubMed ID: 33498001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.